Cited by 127

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Clinical Applications of Exosomes: A Critical Review

Lee, Kar Wai Alvin, Chan, Lisa Kwin Wah, Hung, Lee Cheuk, Phoebe, Lam Kar Wai, Park, Youngjin, Yi, Kyu-Ho·2024·International Journal of Molecular Sciences

Abstract

Exosomes, small membrane-bound vesicles secreted by cells, have gained significant attention for their therapeutic potential. Measuring 30–100 nm in diameter and derived from various cell types, exosomes play a crucial role in intercellular communication by transferring proteins, lipids, and RNA between cells. This review analyzes existing literature on the clinical applications of exosomes. We conducted a comprehensive search of peer-reviewed articles and clinical trial data to evaluate the benefits, limitations, and challenges of exosome-based therapies. Key areas of focus included regenerative medicine, cancer therapy, gene therapy, and diagnostic biomarkers. This review highlights the vast clinical applications of exosomes. In regenerative medicine, exosomes facilitate tissue repair and regeneration. In cancer therapy, exosomes can deliver therapeutic agents directly to tumor cells. In gene therapy, exosomes serve as vectors for gene delivery. As diagnostic biomarkers, they are useful in diagnosing various diseases. Challenges such as the isolation, purification, and characterization of exosomes were identified. Current clinical trials demonstrate the potential of exosome-based therapies, though they also reveal significant hurdles. Regulatory issues, including the need for standardization and validation of exosome products, are critical for advancing these therapies. While significant progress has been made in understanding exosome biology, further research is essential to fully unlock their clinical potential. Addressing challenges in isolation, purification, and regulatory standardization is crucial for their successful application in clinical practice. This review provides a concise overview of the clinical applications of exosomes, emphasizing both their therapeutic promise and the obstacles that need to be overcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms25147794

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 This Figure illustrates the relative sizes of various biological entities. Exosomes, ranging from 30 to 100 nm, are comparable in size to viruses. Larger extracellular vesicles, known as microvesicles, fall within the 100 nm to 1 µm range. Apoptotic bodies, which are even larger, measure between 1 µm and 5 µm. For comparison, platelets are in the 1 µm to 5 µm range, while cells are significantly larger, measuring 8–12 µm. This Figure highlights the size scale from exosomes to cells, demonstrating the hierarchical structure of these biological components.
Figure 1 This Figure illustrates the relative sizes of various biological entities. Exosomes, ranging from 30 to 100 nm, are comparable in size to viruses. Larger extracellular vesicles, known as microvesicles, fall within the 100 nm to 1 µm range. Apoptotic bodies, which are even larger, measure between 1 µm and 5 µm. For comparison, platelets are in the 1 µm to 5 µm range, while cells are significantly larger, measuring 8–12 µm. This Figure highlights the size scale from exosomes to cells, demonstrating the hierarchical structure of these biological components.CC BY · PubMed Central
Figure 2 Exosomes between the cells (purple-colored) function as intercellular communicators, facilitating the transfer of proteins (green), lipids (red), and RNA (blue).
Figure 2 Exosomes between the cells (purple-colored) function as intercellular communicators, facilitating the transfer of proteins (green), lipids (red), and RNA (blue).CC BY · PubMed Central
Figure 3 The diverse medical applications of exosomes. The arrows represent the various sources and applications of exosomes in different medical fields. The versatile roles of exosomes in advancing medical science offer novel approaches for diagnosis, treatment, and monitoring of various health conditions.
Figure 3 The diverse medical applications of exosomes. The arrows represent the various sources and applications of exosomes in different medical fields. The versatile roles of exosomes in advancing medical science offer novel approaches for diagnosis, treatment, and monitoring of various health conditions.CC BY · PubMed Central
Figure 4 There has been a recent surge in interest in exosomes derived from the human pharynx (EXOP by Sihler Inc., Seoul, Republic of Korea, and Exodew by Hyundai Meditech Inc., Wonju, Republic of Korea). Stem cells collected via swab-based sampling during pharyngeal examinations, such as those conducted for early childhood influenza, are recognized for their outstanding differentiation abilities.
Figure 4 There has been a recent surge in interest in exosomes derived from the human pharynx (EXOP by Sihler Inc., Seoul, Republic of Korea, and Exodew by Hyundai Meditech Inc., Wonju, Republic of Korea). Stem cells collected via swab-based sampling during pharyngeal examinations, such as those conducted for early childhood influenza, are recognized for their outstanding differentiation abilities.CC BY · PubMed Central
Figure 5 Pharyngeal stem cells obtained through swab-based sampling during examinations, such as influenza screenings in early childhood, are recognized for their remarkable differentiation capabilities.
Figure 5 Pharyngeal stem cells obtained through swab-based sampling during examinations, such as influenza screenings in early childhood, are recognized for their remarkable differentiation capabilities.CC BY · PubMed Central
Figure 6 Recent technology using screening to keep the health data of donors and inspections of exosomes.
Figure 6 Recent technology using screening to keep the health data of donors and inspections of exosomes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 60

  1. Hessvik, 2018, Current knowledge on exosome biogenesis and release, Cell. Mol. Life Sci., 75, 193, 10.1007/s00018-017-2595-9 · DOI · Paper page
  2. Parker, 1999, The exosome: A proteasome for RNA?, Cell, 99, 347, 10.1016/S0092-8674(00)81520-2 · DOI
  3. Lai, 2022, Exosome Processing and Characterization Approaches for Research and Technology Development, Adv. Sci., 9, e2103222, 10.1002/advs.202103222 · DOI · Paper page
  4. Bobrie, 2011, Exosome secretion: Molecular mechanisms and roles in immune responses, Traffic, 12, 1659, 10.1111/j.1600-0854.2011.01225.x · DOI
  5. Yamashita, 2018, Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application, Biol. Pharm. Bull., 41, 835, 10.1248/bpb.b18-00133 · DOI
  6. Trindade, 2021, Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease, J. Neurochem., 156, 162, 10.1111/jnc.15112 · DOI
  7. Sheridan, 2016, Exosome cancer diagnostic reaches market, Nat. Biotechnol., 34, 359, 10.1038/nbt0416-359 · DOI
  8. Xu, 2019, Exosome: An Emerging Source of Biomarkers for Human Diseases, Curr. Mol. Med., 19, 387, 10.2174/1566524019666190429144310 · DOI
  9. Jiang, 2019, Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer, Mol. Pharm., 16, 3333, 10.1021/acs.molpharmaceut.9b00409 · DOI
  10. Li, X., Corbett, A.L., Taatizadeh, E., Tasnim, N., Little, J.P., Garnis, C., Daugaard, M., Guns, E., Hoorfar, M., and Li, I.T.S. (2019). Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy. APL Bioeng., 3. · DOI
  11. Ludwig, N., Whiteside, T.L., and Reichert, T.E. (2019). Challenges in Exosome Isolation and Analysis in Health and Disease. Int. J. Mol. Sci., 20. · DOI
  12. Pinto, 2024, Exosomes in the Real World of Medical Aesthetics: A Review, Aesthetic Plast. Surg., 48, 2513, 10.1007/s00266-023-03844-8 · DOI
  13. Hu, 2020, Clinical applications of exosome membrane proteins, Precis. Clin. Med., 3, 54, 10.1093/pcmedi/pbaa007 · DOI
  14. Santos, P., and Almeida, F. (2021). Exosome-Based Vaccines: History, Current State, and Clinical Trials. Front. Immunol., 12. · DOI
  15. Song, 2021, The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next, Am. J. Reprod. Immunol., 85, e13329, 10.1111/aji.13329 · DOI
  16. Aheget, H., Tristán-Manzano, M., Mazini, L., Cortijo-Gutierrez, M., Galindo-Moreno, P., Herrera, C., Martin, F., Marchal, J.A., and Benabdellah, K. (2020). Exosome: A New Player in Translational Nanomedicine. J. Clin. Med., 9. · DOI
  17. Wang, 2023, Recent progress in exosome research: Isolation, characterization and clinical applications, Cancer Gene Ther., 30, 1051, 10.1038/s41417-023-00617-y · DOI
  18. Hood, 2012, A systematic approach to exosome-based translational nanomedicine, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 4, 458, 10.1002/wnan.1174 · DOI
  19. 2020, State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: A review, Crit. Rev. Biotechnol., 40, 804, 10.1080/07388551.2020.1785385 · DOI
  20. Das, 2019, Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers, Mol. Pharm., 16, 24, 10.1021/acs.molpharmaceut.8b00901 · DOI
  21. Gurunathan, 2021, A Comprehensive Review on Factors Influences Biogenesis, Functions, Therapeutic and Clinical Implications of Exosomes, Int. J. Nanomed., 16, 1281, 10.2147/IJN.S291956 · DOI
  22. Edelstein, L., Smythies, J., Quesenberry, P., and Noble, D. (2020). Chapter 20—The potential of exosomes as theragnostics in various clinical situations. Exosomes, Academic Press.
  23. Mendt, 2019, Mesenchymal stem cell-derived exosomes for clinical use, Bone Marrow. Transplant., 54, 789, 10.1038/s41409-019-0616-z · DOI
  24. Perocheau, 2021, Clinical applications for exosomes: Are we there yet?, Br. J. Pharmacol., 178, 2375, 10.1111/bph.15432 · DOI · Paper page
  25. Rezaie, 2022, A review on exosomes application in clinical trials: Perspective, questions, and challenges, Cell. Commun. Signal., 20, 145, 10.1186/s12964-022-00959-4 · DOI
  26. Urbanelli, 2015, Exosome-based strategies for Diagnosis and Therapy, Recent Pat. CNS Drug Discov., 10, 10, 10.2174/1574889810666150702124059 · DOI
  27. Cully, 2021, Exosome-based candidates move into the clinic, Nat. Rev. Drug. Discov., 20, 6, 10.1038/d41573-020-00220-y · DOI
  28. Batrakova, 2016, Development and regulation of exosome-based therapy products, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 8, 744, 10.1002/wnan.1395 · DOI
  29. Harrell, C.R., Jovicic, N., Djonov, V., and Volarevic, V. (2020). Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics. Pharmaceutics., 12. · DOI
  30. Lee, B.C., Kang, I., and Yu, K.R. (2021). Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes. J. Clin. Med., 10. · DOI
  31. Chen, 2020, Exosomes in clinical trial and their production in compliance with good manufacturing practice, Ci Ji Yi Xue Za Zhi, 32, 113
  32. Lotfy, 2023, Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials, Stem. Cell. Res. Ther., 14, 66, 10.1186/s13287-023-03287-7 · DOI · Paper page
  33. Chung, 2020, Exosomes: Current use and future applications, Clin. Chim. Acta, 500, 226, 10.1016/j.cca.2019.10.022 · DOI
  34. Vitha, 2019, Characterization and Therapeutic Uses of Exosomes: A New Potential Tool in Orthopedics, Stem. Cells Dev., 28, 141, 10.1089/scd.2018.0205 · DOI
  35. Popowski, 2020, Exosome therapeutics for lung regenerative medicine, J. Extracell. Vesicles, 9, 1785161, 10.1080/20013078.2020.1785161 · DOI
  36. Sanghani, 2022, Advances in exosome therapies in ophthalmology-From bench to clinical trial, Acta. Ophthalmol., 100, 243, 10.1111/aos.14932 · DOI
  37. Kost, 2022, Exosome therapy in hair regeneration: A literature review of the evidence, challenges, and future opportunities, J. Cosmet. Dermatol., 21, 3226, 10.1111/jocd.15008 · DOI
  38. Kavya, A.N.L., Subramanian, S., and Ramakrishna, S. (2022). Therapeutic applications of exosomes in various diseases: A review. Biomater. Adv., 134. · DOI
  39. Salarpour, 2022, The application of exosomes and Exosome-nanoparticle in treating brain disorders, J. Mol. Liq., 350, 118549, 10.1016/j.molliq.2022.118549 · DOI
  40. Willis, G.R., Kourembanas, S., and Mitsialis, S.A. (2017). Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency. Front. Cardiovasc. Med., 4. · DOI
  41. Huda, 2021, Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications, ACS Biomater. Sci. Eng., 7, 2106, 10.1021/acsbiomaterials.1c00217 · DOI
  42. Sun, 2014, Potential of cancer cell-derived exosomes in clinical application: A review of recent research advances, Clin. Ther., 36, 863, 10.1016/j.clinthera.2014.04.018 · DOI
  43. Xu, 2020, Exosome-based immunotherapy: A promising approach for cancer treatment, Mol. Cancer, 19, 160, 10.1186/s12943-020-01278-3 · DOI · Paper page
  44. Zipkin, 2019, Exosome redux, Nat. Biotechnol., 37, 1395, 10.1038/s41587-019-0326-5 · DOI
  45. Tai, 2018, Exosomes in cancer development and clinical applications, Cancer Sci., 109, 2364, 10.1111/cas.13697 · DOI · Paper page
  46. Skuratovskaia, 2021, Exosome Limitations in the Treatment of Inflammatory Diseases, Curr. Pharm. Des., 27, 3105, 10.2174/1381612826666201210120444 · DOI
  47. Lu, 2019, The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application, J. Cardiovasc. Transl. Res., 12, 68, 10.1007/s12265-018-9796-y · DOI
  48. Dimik, 2023, The exosome: A review of current therapeutic roles and capabilities in human reproduction, Drug Deliv. Transl. Res., 13, 473, 10.1007/s13346-022-01225-3 · DOI
  49. He, 2018, Exosome Theranostics: Biology and Translational Medicine, Theranostics, 8, 237, 10.7150/thno.21945 · DOI
  50. Dorayappan, 2016, The biological significance and clinical applications of exosomes in ovarian cancer, Gynecol. Oncol., 142, 199, 10.1016/j.ygyno.2016.03.036 · DOI
  51. Lorenc, T., Chrzanowski, J., and Olejarz, W. (2020). Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics. Cancers, 12. · DOI
  52. Codispoti, B., Marrelli, M., Paduano, F., and Tatullo, M. (2018). NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine. J. Clin. Med., 7. · DOI
  53. Tang, 2020, The cancer exosomes: Clinical implications, applications and challenges, Int. J. Cancer, 146, 2946, 10.1002/ijc.32762 · DOI
  54. Wang, J., Zheng, Y., and Zhao, M. (2016). Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells. Front. Pharmacol., 7. · DOI
  55. Tzng, 2023, Current challenges surrounding exosome treatments, Extracell. Vesicle, 2, 100023, 10.1016/j.vesic.2023.100023 · DOI
  56. Nafar, 2022, Exosome as a target for cancer treatment, J. Investig. Med., 70, 1212, 10.1136/jim-2021-002194 · DOI
  57. Xiong, 2021, The novel mechanisms and applications of exosomes in dermatology and cutaneous medical aesthetics, Pharmacol. Res., 166, 105490, 10.1016/j.phrs.2021.105490 · DOI
  58. Yi, 2024, Skin boosters: Definitions and varied classifications, Skin. Res. Technol., 30, e13627, 10.1111/srt.13627 · DOI · Paper page
  59. Seo, 2023, Ginseng-derived exosome-like nanovesicles extracted by sucrose gradient ultracentrifugation to inhibit osteoclast differentiation, Nanoscale, 15, 5798, 10.1039/D2NR07018A · DOI
  60. Jang, J., Jeong, H., Jang, E., Kim, E., Yoon, Y., Jang, S., Jeong, H.S., and Jang, G. (2022). Isolation of high-purity and high-stability exosomes from ginseng. Front. Plant. Sci., 13. · DOI

Cited by

Sorted by citations

See all 127

Metadata

Authors
Lee, K. W. A., Chan, L. K. W., Hung, L. C., Phoebe, L. K. W., Park, Y., & Yi, K.-H.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-07-16
Volume
25
Issue
14
Pages
7794
ISSN
1422-0067
Cited by
127
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Applications of Exosomes: A Critical Review. https://app.cochat.ai/papers/10.3390/ijms25147794
The paper
Lee, K. W. A., Chan, L. K. W., Hung, L. C., Phoebe, L. K. W., Park, Y., & Yi, K.-H. (2024). Clinical Applications of Exosomes: A Critical Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147794